UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Searching for ways to make money today fast? Explore quick and effective ideas to boost your income and achieve financial goals.
20,859 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Datadog stock has slid significantly from its 52-week peak, drawing bargain hunters. This deep dive explains whether ...
Navigate Greenlight Re’s GLRE earnings call with a clear eye on underwriting results, investment income, and capital ...
Brent crude holds near $92 as global supply and demand signals shape the March 2026 market. Analysts flag continued v...
Investors are weighing whether to buy Nvidia stock before a key date. This practical guide lays out a framework, scen...
A new study shows the king penguins rare species breeding earlier and more successfully, marking a rare climate-drive...
Oil prices rose above $100 a barrel after a large emergency stockpile release. Yet investor fears lingered about supp...
Rivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
Former Indeed CEO Chris Hyams argues the real AI danger comes from the people steering the technology, not the code. ...
The White House-backed gala for TRUMP holders comes as the meme coin rebounds strongly following a trough, pushing th...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
Amkor Technology and Ichor Holdings report Q4 2025 results, underscoring their roles as AI hardware enablers as the m...